Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (421-430 of 683) with videos related to

Pageof 69
Sort By:
Molecular Cancer Research : MCR|February 12, 2009
Yin yang 1 modulates taxane response in epithelial ovarian cancerNoriomi Matsumura, Zhiqing Huang, Tsukasa Baba, et al.
Gynecologic Oncology|May 8, 2026
Estrogen hormone therapy use in ovarian cancer patients under age 60 at diagnosisAlexandra Lukey, Ali Salmanpour, Paramdeep Kaur, et al.
Communications Medicine|July 10, 2026
Characterizing the composition and diversity of the vaginal microbiome in ovarian cancerApril Deveaux, Oyomoare L Osazuwa-Peters, Yeon Ji Kim, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 27, 2022
Associations of Healthcare Affordability, Availability, and Accessibility with Quality Treatment Metrics in Patients with Ovarian CancerTomi F Akinyemiju, Lauren E Wilson, Nicole Diaz, et al.
BMC Women'S Health|August 29, 2025
Human papillomavirus infection among patients with cervical cancer in CambodiaJacob E Gardner, Kyle Jung, Michel Pluot, et al.
BMJ Open|October 5, 2021
Ovarian Cancer Epidemiology, Healthcare Access and Disparities (ORCHiD): methodology for a population-based study of black, Hispanic and white patients with ovarian cancerTomi Akinyemiju, April Deveaux, Lauren Wilson, et al.
Nature|November 8, 2005
Oncogenic pathway signatures in human cancers as a guide to targeted therapiesAndrea H Bild, Guang Yao, Jeffrey T Chang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023
The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinomaB A McGregor, G P Sonpavde, L Kwak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2004
Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributionsSteven J Skates, Nora Horick, Yinhua Yu, et al.
Annals of Surgical Oncology|September 23, 2006
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromesJosé G Guillem, William C Wood, Jeffrey F Moley, et al.
Pageof 69

Showing results (421-430 of 683) with videos related to

Sort By:
Pageof 69
Molecular Cancer Research : MCR|February 12, 2009
Yin yang 1 modulates taxane response in epithelial ovarian cancerNoriomi Matsumura, Zhiqing Huang, Tsukasa Baba, et al.
Gynecologic Oncology|May 8, 2026
Estrogen hormone therapy use in ovarian cancer patients under age 60 at diagnosisAlexandra Lukey, Ali Salmanpour, Paramdeep Kaur, et al.
Communications Medicine|July 10, 2026
Characterizing the composition and diversity of the vaginal microbiome in ovarian cancerApril Deveaux, Oyomoare L Osazuwa-Peters, Yeon Ji Kim, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 27, 2022
Associations of Healthcare Affordability, Availability, and Accessibility with Quality Treatment Metrics in Patients with Ovarian CancerTomi F Akinyemiju, Lauren E Wilson, Nicole Diaz, et al.
BMC Women'S Health|August 29, 2025
Human papillomavirus infection among patients with cervical cancer in CambodiaJacob E Gardner, Kyle Jung, Michel Pluot, et al.
BMJ Open|October 5, 2021
Ovarian Cancer Epidemiology, Healthcare Access and Disparities (ORCHiD): methodology for a population-based study of black, Hispanic and white patients with ovarian cancerTomi Akinyemiju, April Deveaux, Lauren Wilson, et al.
Nature|November 8, 2005
Oncogenic pathway signatures in human cancers as a guide to targeted therapiesAndrea H Bild, Guang Yao, Jeffrey T Chang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023
The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinomaB A McGregor, G P Sonpavde, L Kwak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2004
Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributionsSteven J Skates, Nora Horick, Yinhua Yu, et al.
Annals of Surgical Oncology|September 23, 2006
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromesJosé G Guillem, William C Wood, Jeffrey F Moley, et al.
Pageof 69